Riskpilot← Back to searchSign inGet full accessDiagnostics Development Sweden AB
ABActiveOrg 5566124078Skolgatan 23Retail sale of second-hand goods · NACE 4779Est. 20016 employees
Revenue 2024
SEK 7M
+38% vs 2023
EBITDA margin
40.2%
+353% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
SEK 1,9M
+546% vs 2023
| Revenue | SEK 7M | +38% |
| EBITDA | SEK 2,8M | +353% |
| Net profit | SEK 1,9M | +546% |
| Total assets | SEK 9,8M | +37% |
| Equity | SEK 6,8M | +38% |
| Employees | 6 | — |
Legal name
Diagnostics Development Sweden AB
Org number
5566124078
Legal form
Aktiebolag
NACE code
4779 · Retail sale of second-hand goods
Founded
27 juni 2001
Share capital
SEK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Venge, Klara Margareta Venge, Per Sören Wendelboe
Company purpose
Bolaget skall bedriva forskning och utveckling av medicinsk diagnostik samt medicinteknologisk konsultverksamhet samt därmed förenlig verksamhet.
Address
Skolgatan 23
Phone
+46706268083
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 037 | 6 473 | 2 504 | 5 041 | 6 956 |
| Staff expenses | — | — | −2 016 | −1 959 | −2 135 |
| EBITDA | −831 | 857 | −1 455 | 617 | 2 797 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −831 | 857 | −1 455 | 617 | 2 797 |
| Net financials | −35 | −214 | 872 | −457 | 132 |
| Profit before tax | −866 | 735 | −583 | −420 | 2 129 |
| Tax | −0 | −0 | — | — | −256 |
| Net profit | −866 | 735 | −583 | −420 | 1 873 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 359 | 8 189 | 6 269 | 7 130 | 9 768 |
| Equity | 5 239 | 5 973 | 5 390 | 4 970 | 6 843 |
| Long-term debt | 853 | 755 | 0 | — | 807 |
| Short-term debt | 1 267 | 1 461 | 879 | 2 160 | 2 118 |
| Total debt | 2 120 | 2 216 | 879 | 2 160 | 2 925 |
EBITDA margin
40.2%
This company
15.8%
Market median
+154% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
27.4%
This company
18.4%
Market median
+49% vs market
20202024
Net profit margin
26.9%
This company
8.1%
Market median
+232% vs market
20202024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KO Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
| Audit | 2021 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (8) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kvarnhagen Holding AB
Diagnostics Development Sweden AB Board members of Diagnostics Development Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenth Olof Nordin | Chief Auditor | 0 companies |
| Karin Margareta Thorsell Gustafsson | Audit | 0 companies |
| Per Sören Wendelboe Venge | Chairman | 0 companies |
| Martin Wendelboe Venge | Board of Directors | 0 companies |
| Klara Margareta Venge | Board of Directors | 0 companies |
| Ann-Katrin Eriksson | Deputy Board Member | 0 companies |
| Andreas Wendelboe Venge | Board of Directors | 0 companies |
| Carl Jonas Wendelbo Venge | Board of Directors | 0 companies |
| Agnes Caroline Aurore Venge | Deputy Board Member | 0 companies |
| Mipa Marianne Venge | Deputy Board Member | 0 companies |